Background-Nitric oxide (NO) is an unstable vasodilator formed by NO synthetase (NOS) from L-arginine (L-Arg) in various cells but its role in the control of pancreatic secretion in humans has not been examined. Aims-This study was designed to determine the role of endogenous NO in the control ofexocrine and endocrine pancreas using NOS inhibitor, NG-monomethyl-L-Arg (L-NMMA). Methods-Pancreatic secretion was stimulated by intravenous infusion of secretin (80 pmol/kglh) plus caerulein (50 pmollkglh) and duodenal content was aspirated by gastroduodenal tube. Two series of tests with secretagogue infusion were performed, one, with addition of graded doses of L-NMMA and, another, with addition of a constant dose of L-Arg alone followed by L-NMMA alone and finally by a combination of L-Arg and L-NMMA. Results-Addition of L-NMMA in graded doses (2-8 ,imol/kg/h) reduced dose dependently the secretin-caerulein stimulated pancreatic enzyme secretion without alterations in the volume flow and bicarbonate outputs. The addition of L-Arg to L-NMMA reversed the inhibitory action of L-NMMA on protein enzyme response to secretin-caerulein in these subjects. Secretin-caerulein infusion caused significant increase in plasma insulin and pancreatic polypeptide levels but without changes in plasma glucagon or somatostatin levels. L-NMMA alone resulted in a significant fall in plasma insulin and pancreatic polypeptide levels, while L-Arg added to pancreatic secretagogue infusion caused a significant increase of plasma insulin and pancreatic polypeptide levels above those attained with secretagogues alone. After the addition of L-Arg to L-NMMA, both plasma insulin and pancreatic polypeptide levels rose significantly above the levels observed with L-NMMA plus secretin-CCK stimulation.
Nitric oxide (NO), originally known as endothelium derived relaxing factor,' is an unstable vasodilator released by endothelial cells2 3 This study was designed to use selective NOS inhibitor, L-NMMA, and the substrate of NOS, L-Arg, in healthy humans to evaluate the role of endogenous NO in the control of exocrine pancreatic secretion stimulated by secretin plus caerulein and of endocrine pancreatic islet hormones such as insulin glucagon, pancreatic polypeptide (PP) , and somatostatin in healthy men. Pulse rate, mean arterial blood pressure, and subjective symptoms were monitored throughout the administration of L-NMMA.
Methods
Basal and secretagogue induced duodenal volume and secretory outputs of bicarbonate, protein, and enzymes were determined. These ; outputs were corrected by PEG recovery and the infusion rate of PEG was subtracted from that recovered from the duodenum.
All results are expressed as means (SEM). The significance of the differences between the control secretory outputs or plasma hormone concentrations and those obtained with administration of L-NMMA was evaluated by 80 Student's test for paired samples. Statistical significance was set at the 5% level. T These secretory peaks were followed by a relatively well sustained secretory plateau throughout the period of infusion. Addition of L-NMMA in gradually increasing doses to iv infusion of pancreatic secretagogues did not change significantly the volume flow and bicarbonate outputs at any dose used. In contrast, the protein outputs, which in control tests reached the peak (about 69 (8) be involved in the mechanism of enzyme secretion by acinar cells. On the other hand, the finding that L-NMMA attenuated the pancreatic blood flow both in resting and itinliulatlion hormonally stimulated pancreas in dogs" and sesw7thower rats'4 and that this effect could be reversed by the addition of L-Arg (but not D-Arg) to L-NMMA suggests that endogenous NO may affect the pancreatic secretion, at least in part, ollkg/h), through the changes in vascular bed.
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Both direct effects on acinar cells and its Hg over indirect influence on pancreatic secretion admin-through pancreatic blood flow are in keeping with the findings that NOS can be visualised secreta-by immunocytochemistry using specific antilition of bodies against NOS and by histochemistry irded in using nicotiamide adenine dinucleotide hydrogen phosphate-diaphorase (NADPH-d) as a As shown in this study on humans, the suppression of NOS by L-NMMA resulted in the reduction in secretagogue stimulated increment in plasma insulin and PP levels. As these effects were reversed by the addition of L-Arg to L-NMMA, the results could be interpreted that endogenous NO in humans contributes to the release of insulin and PP and remains in agreement with previous reports demonstrating the presence of NOS in varicose nerve terminals within the pancreatic islets and in the islet cell itself. 6 7 The mechanisms of exocrine and endocrine pancreatic secretion involve a variety of neurohormonal factors among which non-adrenergic 
